HappeningToo topic
Clindamycin Phosphate reports
Browse community reports connected to Clindamycin Phosphate. These reports can show that other people are describing similar experiences, but they do not prove that Clindamycin Phosphate caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
42 problems
Abdominal Discomfort while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and abdominal discomfort appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and abdominal pain upper appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and abdominal pain appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Acid reflux while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and acid reflux appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and alopecia appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and anxiety appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and back pain appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chest Discomfort while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and chest discomfort appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chills while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and chills appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and constipation appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and cough appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and decreased appetite appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and dehydration appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and diarrhea appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and dizziness appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dyspepsia while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and dyspepsia appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and fatigue appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and feeling abnormal appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and headache appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and hives appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and hypotension appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and insomnia appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and itching appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and malaise appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and muscle spasms appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and myalgia appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and nausea appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Oropharyngeal Pain while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and oropharyngeal pain appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and pain appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and peripheral swelling appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash Maculo-papular while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and rash maculo-papular appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and rash appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and shortness of breath appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and skin redness appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and sleepiness appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Swelling while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and swelling appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tachycardia while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and tachycardia appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and tingling or pins and needles appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and vomiting appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and weakness appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and weight decreased appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Clindamycin Phosphate
FDA FAERS contains adverse-event reports in which Clindamycin Phosphate and weight increased appear together. This does not establish that Clindamycin Phosphate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →